Telomeres and immunological diseases of aging

Gerontology

Volumn 56, Issue 4, 2010, Pages 390-403

  Andrews, Nicolas P ^a   Fujii, Hiroshi ^a   Goronzy, Jörg J ^a   Weyand, Cornelia M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Immunosenescence; Telomeres

Indexed keywords

NUCLEOPROTEIN; TELOMERASE;

AGING; APOPTOSIS; ATOPIC DERMATITIS; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CHROMOSOME REPLICATION; CHRONIC INFLAMMATION; FIBROSING ALVEOLITIS; GENOMIC INSTABILITY; HISTIOCYTOSIS X; HUMAN; IMMUNOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTE; OBESITY; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SENESCENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TELOMERE; WEGENER GRANULOMATOSIS; ANIMAL; BIOLOGICAL MODEL; CELL AGING; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PREMATURE AGING; T LYMPHOCYTE;

AGING; AGING, PREMATURE; ANIMALS; CELL AGING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNE SYSTEM DISEASES; INFLAMMATION; MODELS, BIOLOGICAL; T-LYMPHOCYTES; TELOMERASE; TELOMERE;

EID: 77953812233     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000268620     Document Type: Review

References (148)

1. Sarkar D, Fisher PB: Molecular mechanisms of aging-associated inflammation. Cancer Lett 2006; 236: 13-23.
2. Goronzy JJ, Weyand CM: Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther 2003; 5: 225-234.
3. Shay JW, Wright WE: Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005; 26: 867-874.
4. Palm W, de Lange T: How shelterin protects mammalian telomeres. Annu Rev Genet 2008; 42: 301-334.
5. Bollmann FM: The many faces of telomerase: emerging extratelomeric effects. Bioessays 2008; 30: 728-732.
6. Hayflick L, Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25: 585-621.
7. Gilson E, Londono-Vallejo A: Telomere length profiles in humans: all ends are not equal. Cell Cycle 2007; 6: 2486-2494.
8. Verdun RE, Karlseder J: Replication and protection of telomeres. Nature 2007; 447: 924-931.
9. Hemann MT, Strong MA, Hao LY, Greider CW: The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001; 107: 67-77.
10. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, de Lange T: Mammalian telomeres end in a large duplex loop. Cell 1999; 97: 503-514.
11. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB, Brooks MW, Kaneko S, Murakami S, DeCaprio JA, Weinberg RA, Stewart SA, Hahn WC: Telomerase maintains telomere structure in normal human cells. Cell 2003; 114: 241-253.
12. Anno K, Hayashi A, Takahashi T, Mitsui Y, Ide T, Tahara H: Telomerase activation induces elongation of the telomeric singlestranded overhang, but does not prevent chromosome aberrations in human vascular endothelial cells. Biochem Biophys Res Commun 2007; 353: 926-932.
13. Stansel RM, de Lange T, Griffith JD: T-loop assembly in vitro involves binding of TRF2 near the 3- telomeric overhang. Embo J 2001; 20: 5532-5540.
14. de Lange T: Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19: 2100-2110.
15. Longhese MP: DNA damage response at functional and dysfunctional telomeres. Genes Dev 2008; 22: 125-140.
16. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T: P53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999; 283: 1321-1325.
17. Denchi EL, de Lange T: Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 2007; 448: 1068-1071.
18. Williams ES, Klingler R, Ponnaiya B, Hardt T, Schrock E, Lees-Miller SP, Meek K, Ullrich RL, Bailey SM: Telomere dysfunction and DNA-PKcs deficiency: characterization and consequence. Cancer Res 2009; 69: 2100-2107.
19. Akbar AN, Beverley PC, Salmon M: Will telomere erosion lead to a loss of T-cell memory? Nat Rev Immunol 2004; 4: 737-743.
20. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015.
21. Kyo S, Kanaya T, Takakura M, Tanaka M, Yamashita A, Inoue H, Inoue M: Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int J Cancer 1999; 80: 804-809.
22. Horikawa I, Cable PL, Afshari C, Barrett JC: Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 1999; 59: 826-830. (Pubitemid 29086735)
23. Wu KJ, Grandori C, Amacker M, Simon- Vermot N, Polack A, Lingner J, Dalla-Favera R: Direct activation of TERT transcription by c-Myc. Nat Genet 1999; 21: 220-224.
24. Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H, Inoue M: Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res 2000; 28: 669-677.
25. Goueli BS, Janknecht R: Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor. Oncogene 2003; 22: 8042-8047.
26. Yatabe N, Kyo S, Maida Y, Nishi H, Nakamura M, Kanaya T, Tanaka M, Isaka K, Ogawa S, Inoue M: Hif-1-mediated activation of telomerase in cervical cancer cells. Oncogene 2004; 23: 3708-3715.
27. Lv J, Liu H, Wang Q, Tang Z, Hou L, Zhang B: Molecular cloning of a novel human gene encoding histone acetyltransferase-like protein involved in transcriptional activation of hTERT. Biochem Biophys Res Commun 2003; 311: 506-513.
28. Nishi H, Nakada T, Kyo S, Inoue M, Shay JW, Isaka K: Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Mol Cell Biol 2004; 24: 6076-6083.
29. Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H, Inoue M: Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin Cancer Res 2000; 6: 1239-1247.
30. Takakura M, Kyo S, Inoue M, Wright WE, Shay JW: Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells. Mol Cell Biol 2005; 25: 8037-8043.
31. Oh S, Song Y, Yim J, Kim TK: The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene. J Biol Chem 1999; 274: 37473-37478.
32. Oh S, Song YH, Yim J, Kim TK: Identification of Mad as a repressor of the human telomerase (hTERT) gene. Oncogene 2000; 19: 1485-1490.
33. Fujimoto K, Kyo S, Takakura M, Kanaya T, Kitagawa Y, Itoh H, Takahashi M, Inoue M: Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT. Nucleic Acids Res 2000; 28: 2557-2562.
34. Renaud S, Loukinov D, Bosman FT, Lobanenkov V, Benhattar J: CTCF binds the proximal exonic region of hTERT and inhibits its transcription. Nucleic Acids Res 2005; 33: 6850-6860.
35. Li H, Xu D, Li J, Berndt MC, Liu JP: Transforming growth factor beta suppresses human telomerase reverse transcriptase (hTERT) by Smad3 interactions with c-Myc and the hTERT gene. J Biol Chem 2006; 281: 25588-25600.
36. Lou F, Chen X, Jalink M, Zhu Q, Ge N, Zhao S, Fang X, Fan Y, Bjorkholm M, Liu Z, Xu D: The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase. Mol Cancer Res 2007; 5: 793-800.
37. Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE: Hif-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J 2004; 23: 1949-1956.
38. Choi J, Fauce SR, Effros RB: Reduced telomerase activity in human T lymphocytes exposed to cortisol. Brain Behav Immun 2008; 22: 600-605.
39. Kang SS, Kwon T, Kwon DY, Do SI: Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem 1999; 274: 13085-13090.
40. Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, Mitsiades N, Chauhan D, Richardson P, Munshi NC, Anderson KC: Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res 2003; 63: 18-21.
41. Robertson KD, Jones PA: DNA methylation: past, present and future directions. Carcinogenesis 2000; 21: 461-467.
42. Kumakura S, Tsutsui TW, Yagisawa J, Barrett JC, Tsutsui T: Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells. Cancer Res 2005; 65: 2778-2786.
43. Renaud S, Loukinov D, Abdullaev Z, Guilleret I, Bosman FT, Lobanenkov V, Benhattar J: Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res 2007; 35: 1245-1256.
44. Wilson VL, Smith RA, Ma S, Cutler RG: Genomic 5-methyldeoxycytidine decreases with age. J Biol Chem 1987; 262: 9948-9951.
45. Cong YS, Bacchetti S: Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells. J Biol Chem 2000; 275: 35665-35668.
46. Xu D, Popov N, Hou M, Wang Q, Bjorkholm M, Gruber A, Menkel AR, Henriksson M: Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci USA 2001; 98: 3826-3831.
47. Won J, Yim J, Kim TK: Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. J Biol Chem 2002; 277: 38230-38238.
48. Vulliamy TJ, Dokal I: Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex. Biochimie 2008; 90: 122-130. (Pubitemid 350216210)
49. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I: The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001; 413: 432-435. (Pubitemid 32928599)
50. Walne AJ, Vulliamy T, Marrone A, Beswick R, Kirwan M, Masunari Y, Al-Qurashi FH, Aljurf M, Dokal I: Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet 2007; 16: 1619-1629.
51. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, Dokal I: X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998; 19: 32-38.
52. Meier UT: The many facets of H/ACA ribonucleoproteins. Chromosoma 2005; 114: 1-14.
53. Wong JM, Collins K: Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. Genes Dev 2006; 20: 2848-2858.
54. Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I: Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet 2004; 36: 447-449.
55. Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I: Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood 2006; 107: 2680-2685.
56. Yamaguchi H, Calado RT, Ly H, Kajigaya S, Baerlocher GM, Chanock SJ, Lansdorp PM, Young NS: Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med 2005; 352: 1413-1424.
57. Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP: TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet 2008; 82: 501-509.
58. Lavin MF: Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 2008; 9: 759-769.
59. Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y: Requirement of the MRN complex for ATM activation by DNA damage. EMBO J 2003; 22: 5612-5621.
60. Lee JH, Paull TT: ATM activation by DNA double-strand breaks through the Mre11- Rad50-Nbs1 complex. Science 2005; 308: 551-554.
61. Digweed M, Sperling K: Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA Repair (Amst) 2004; 3: 1207-1217.
62. Stewart GS, Maser RS, Stankovic T, Bressan DA, Kaplan MI, Jaspers NG, Raams A, Byrd PJ, Petrini JH, Taylor AM: The DNA doublestrand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasialike disorder. Cell 1999; 99: 577-587.
63. Helmink BA, Bredemeyer AL, Lee BS, Huang CY, Sharma GG, Walker LM, Bednarski JJ, Lee WL, Pandita TK, Bassing CH, Sleckman BP: MRN complex function in the repair of chromosomal Rag-mediated DNA doublestrand breaks. J Exp Med 2009; 206: 669-679.
64. Callen E, Samper E, Ramirez MJ, Creus A, Marcos R, Ortega JJ, Olive T, Badell I, Blasco MA, Surralles J: Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia. Hum Mol Genet 2002; 11: 439-444.
65. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-3715.
66. Igarashi H, Sakaguchi N: Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood 1997; 89: 1299-1307.
67. Liu K, Schoonmaker MM, Levine BL, June CH, Hodes RJ, Weng NP: Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci USA 1999; 96: 5147-5152.
68. Sheng WY, Chen YR, Wang TC: A major role of PKC theta and NFkappaB in the regulation of hTERT in human T lymphocytes. FEBS Lett 2006; 580: 6819-6824.
69. Akiyama M, Yamada O, Hideshima T, Yanagisawa T, Yokoi K, Fujisawa K, Eto Y, Yamada H, Anderson KC: TNFalpha induces rapid activation and nuclear translocation of telomerase in human lymphocytes. Biochem Biophys Res Commun 2004; 316: 528-532.
70. Li H, Zhao LL, Funder JW, Liu JP: Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J Biol Chem 1997; 272: 16729-16732. (Pubitemid 27289765)
71. Reed JR, Vukmanovic-Stejic M, Fletcher JM, Soares MV, Cook JE, Orteu CH, Jackson SE, Birch KE, Foster GR, Salmon M, Beverley PC, Rustin MH, Akbar AN: Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. J Exp Med 2004; 199: 1433-1443.
72. Surh CD, Sprent J: Homeostasis of naive and memory T cells. Immunity 2008; 29: 848-862.
73. Soares MV, Borthwick NJ, Maini MK, Janossy G, Salmon M, Akbar AN: IL-7-dependent extrathymic expansion of CD45RA + T cells enables preservation of a naive repertoire. J Immunol 1998; 161: 5909-5917.
74. Wallace DL, Berard M, Soares MV, Oldham J, Cook JE, Akbar AN, Tough DF, Beverley PC: Prolonged exposure of naive CD8 + T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length. Immunology 2006; 119: 243-253.
75. Slagboom PE, Droog S, Boomsma DI: Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 1994; 55: 876-882.
76. Nordfjall K, Larefalk A, Lindgren P, Holmberg D, Roos G: Telomere length and heredity: indications of paternal inheritance. Proc Natl Acad Sci USA 2005; 102: 16374-16378.
77. Frenck RW Jr., Blackburn EH, Shannon KM: The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci USA 1998; 95: 5607-5610.
78. Rufer N, Brummendorf TH, Kolvraa S, Bischoff C, Christensen K, Wadsworth L, Schulzer M, Lansdorp PM: Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 1999; 190: 157-167.
79. Hodes RJ, Hathcock KS, Weng NP: Telomeres in T and B cells. Nat Rev Immunol 2002; 2: 699-706.
80. Aviv A, Chen W, Gardner JP, Kimura M, Brimacombe M, Cao X, Srinivasan SR, Berenson GS: Leukocyte telomere dynamics: longitudinal findings among young adults in the Bogalusa heart study. Am J Epidemiol 2009; 169: 323-329.
81. Petersen S, Saretzki G, von Zglinicki T: Preferential accumulation of single-stranded regions in telomeres of human fibroblasts. Exp Cell Res 1998; 239: 152-160.
82. Matsubara Y, Murata M, Yoshida T, Watanabe K, Saito I, Miyaki K, Omae K, Ikeda Y: Telomere length of normal leukocytes is affected by a functional polymorphism of hTERT. Biochem Biophys Res Commun 2006; 341: 128-131.
83. Nordfjall K, Osterman P, Melander O, Nilsson P, Roos G: hTERT (-1327)T/C polymorphism is not associated with age-related telomere attrition in peripheral blood. Biochem Biophys Res Commun 2007; 358: 215-218.
84. Golbus J, Palella TD, Richardson BC: Quantitative changes in T cell DNA methylation occur during differentiation and ageing. Eur J Immunol 1990; 20: 1869-1872.
85. Damjanovic AK, Yang Y, Glaser R, Kiecolt- Glaser JK, Nguyen H, Laskowski B, Zou Y, Beversdorf DQ, Weng NP: Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. J Immunol 2007; 179: 4249-4254.
86. Muller FL, Lustgarten MS, Jang Y, Richardson A, Van Remmen H: Trends in oxidative aging theories. Free Radic Biol Med 2007; 43: 477-503.
87. Oikawa S, Kawanishi S: Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett 1999; 453: 365-368.
88. von Zglinicki T: Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339-344.
89. Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, Cherkas LF, Aviv A, Spector TD: Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662-664.
90. Starr JM, McGurn B, Harris SE, Whalley LJ, Deary IJ, Shiels PG: Association between telomere length and heart disease in a narrow age cohort of older people. Exp Gerontol 2007; 42: 571-573.
91. Starr JM, Shiels PG, Harris SE, Pattie A, Pearce MS, Relton CL, Deary IJ: Oxidative stress, telomere length and biomarkers of physical aging in a cohort aged 79 years from the 1932 Scottish Mental Survey. Mech Ageing Dev 2008; 129: 745-751.
92. Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, Alt FW: DNA repair, genome stability, and aging. Cell 2005; 120: 497-512.
93. Andriollo-Sanchez M, Hininger-Favier I, Meunier N, Venneria E, O'Connor JM, Maiani G, Coudray C, Roussel AM: Age-related oxidative stress and antioxidant parameters in middle-aged and older European subjects: the Zenith study. Eur J Clin Nutr 2005; 59(Suppl 2):58-62.
94. Vina J, Borras C, Gambini J, Sastre J, Pallardo FV: Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett 2005; 579: 2541-2545.
95. Lee DC, Im JA, Kim JH, Lee HR, Shim JY: Effect of long-term hormone therapy on telomere length in postmenopausal women. Yonsei Med J 2005; 46: 471-479.
96. Benetos A, Okuda K, Lajemi M, Kimura M, Thomas F, Skurnick J, Labat C, Bean K, Aviv A: Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 2001; 37: 381-385.
97. Okuda K, Bardeguez A, Gardner JP, Rodriguez P, Ganesh V, Kimura M, Skurnick J, Awad G, Aviv A: Telomere length in the newborn. Pediatr Res 2002; 52: 377-381.
98. Engel P, Eck MJ, Terhorst C: The SAP and SLAM families in immune responses and Xlinked lymphoproliferative disease. Nat Rev Immunol 2003; 3: 813-821.
99. Plunkett FJ, Franzese O, Belaramani LL, Fletcher JM, Gilmour KC, Sharifi R, Khan N, Hislop AD, Cara A, Salmon M, Gaspar HB, Rustin MH, Webster D, Akbar AN: The impact of telomere erosion on memory CD8 + T cells in patients with X-linked lymphoproliferative syndrome. Mech Ageing Dev 2005; 126: 855-865.
100. Effros RB, Allsopp R, Chiu CP, Hausner MA, Hirji K, Wang L, Harley CB, Villeponteau B, West MD, Giorgi JV: Shortened telomeres in the expanded CD28-CD8 + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996; 10: F17-F22.
101. Son NH, Murray S, Yanovski J, Hodes RJ, Weng N: Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J Immunol 2000; 165: 1191-1196.
102. Son NH, Joyce B, Hieatt A, Chrest FJ, Yanovski J, Weng NP: Stable telomere length and telomerase expression from naive to memory B-lymphocyte differentiation. Mech Ageing Dev 2003; 124: 427-432.
103. Weng NP: Telomere and adaptive immunity. Mech Ageing Dev 2008; 129: 60-66.
104. Gavazzi G, Krause KH: Ageing and infection. Lancet Infect Dis 2002; 2: 659-666.
105. Dokal I: Dyskeratosis congenita in all its forms. Br J Haematol 2000; 110: 768-779.
106. Effros RB, Boucher N, Porter V, Zhu X, Spaulding C, Walford RL, Kronenberg M, Cohen D, Schachter F: Decline in CD28 + T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol 1994; 29: 601-609.
107. Effros RB: Loss of CD28 expression on T lymphocytes: a marker of replicative senescence. Dev Comp Immunol 1997; 21: 471-478.
108. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, Weyand CM: Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000; 101: 2883-2888.
109. Martens PB, Goronzy JJ, Schaid D, Weyand CM: Expansion of unusual CD4 + T cells in severe rheumatoid arthritis. Arthritis Rheum 1997; 40: 1106-1114.
110. Moosig F, Csernok E, Wang G, Gross WL: Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol 1998; 114: 113-118.
111. Vallejo AN, Weyand CM, Goronzy JJ: T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med 2004; 10: 119-124.
112. Namekawa T, Wagner UG, Goronzy JJ, Weyand CM: Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum 1998; 41: 2108-2116.
113. Valenzuela HF, Effros RB: Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. Clin Immunol 2002; 105: 117-125.
114. Plunkett FJ, Franzese O, Finney HM, Fletcher JM, Belaramani LL, Salmon M, Dokal I, Webster D, Lawson AD, Akbar AN: The loss of telomerase activity in highly differentiated CD8 + CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation. J Immunol 2007; 178: 7710-7719.
115. Rufer N, Migliaccio M, Antonchuk J, Humphries RK, Roosnek E, Lansdorp PM: Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential. Blood 2001; 98: 597-603.
116. Honda M, Mengesha E, Albano S, Nichols WS, Wallace DJ, Metzger A, Klinenberg JR, Linker-Israeli M: Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerasepositive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus. Clin Immunol 2001; 99: 211-221.
117. Artlett CM, Black CM, Briggs DC, Stevens CO, Welsh KI: Telomere reduction in scleroderma patients: a possible cause for chromosomal instability. Br J Rheumatol 1996; 35: 732-737.
118. Schonland SO, Lopez C, Widmann T, Zimmer J, Bryl E, Goronzy JJ, Weyand CM: Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA 2003; 100: 13471-13476.
119. Jeanclos E, Krolewski A, Skurnick J, Kimura M, Aviv H, Warram JH, Aviv A: Shortened telomere length in white blood cells of patients with IDDM. Diabetes 1998; 47: 482-486.
120. Vogt S, Iking-Konert C, Hug F, Andrassy K, Hansch GM: Shortening of telomeres: Evidence for replicative senescence of T cells derived from patients with Wegener's granulomatosis. Kidney Int 2003; 63: 2144-2151.
121. Wu K, Higashi N, Hansen ER, Lund M, Bang K, Thestrup-Pedersen K: Telomerase activity is increased and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis. J Immunol 2000; 165: 4742-4747.
122. Steer SE, Williams FM, Kato B, Gardner JP, Norman PJ, Hall MA, Kimura M, Vaughan R, Aviv A, Spector TD: Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration. Ann Rheum Dis 2007; 66: 476-480.
123. Skapenko A, Lipsky PE, Schulze-Koops H: T cell activation as starter and motor of rheumatic inflammation. Curr Top Microbiol Immunol 2006; 305: 195-211.
124. Goronzy JJ, Bartz-Bazzanella P, Hu W, Jendro MC, Walser-Kuntz DR, Weyand CM: Dominant clonotypes in the repertoire of peripheral CD4 + T cells in rheumatoid arthritis. J Clin Invest 1994; 94: 2068-2076.
125. Schmidt D, Goronzy JJ, Weyand CM: Cd4 + CD7 - CD28 - T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996; 97: 2027-2037.
126. Wagner UG, Koetz K, Weyand CM, Goronzy JJ: Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci USA 1998; 95: 14447-14452.
127. Fujii H, Shao L, Colmegna I, Goronzy JJ, Weyand CM: Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci USA 2009; 106: 4360-4365.
128. Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM: T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA 2000; 97: 9203-9208.
129. Chung HY, Sung B, Jung KJ, Zou Y, Yu BP: The molecular inflammatory process in aging. Antioxid Redox Signal 2006; 8: 572-581.
130. Brod SA: Unregulated inflammation shortens human functional longevity. Inflamm Res 2000; 49: 561-570.
131. van der Harst P, van der Steege G, de Boer RA, Voors AA, Hall AS, Mulder MJ, van Gilst WH, van Veldhuisen DJ: Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol 2007; 49: 1459-1464.
132. Schreurs MW, Hermsen MA, Geltink RI, Scholten KB, Brink AA, Kueter EW, Tijssen M, Meijer CJ, Ylstra B, Meijer GA, Hooijberg E: Genomic stability and functional activity may be lost in telomerase-transduced human CD8 + T lymphocytes. Blood 2005; 106: 2663-2670.
133. Roth A, Yssel H, Pene J, Chavez EA, Schertzer M, Lansdorp PM, Spits H, Luiten RM: Telomerase levels control the lifespan of human T lymphocytes. Blood 2003; 102: 849-857.
134. Menzel O, Migliaccio M, Goldstein DR, Dahoun S, Delorenzi M, Rufer N: Mechanisms regulating the proliferative potential of human CD8 + T lymphocytes overexpressing telomerase. J Immunol 2006; 177: 3657-3668.
135. Fauce SR, Jamieson BD, Chin AC, Mitsuyasu RT, Parish ST, Ng HL, Kitchen CM, Yang OO, Harley CB, Effros RB: Telomerase- based pharmacologic enhancement of antiviral function of human CD8 + T lymphocytes. J Immunol 2008; 181: 7400-7406.
136. De Meyer T, Rietzschel ER, De Buyzere ML, De Bacquer D, Van Criekinge W, De Backer GG, Gillebert TC, Van Oostveldt P, Bekaert S: Paternal age at birth is an important determinant of offspring telomere length. Hum Mol Genet 2007; 16: 3097-3102.
137. Kurosaka D, Yasuda J, Yoshida K, Yokoyama T, Ozawa Y, Obayashi Y, Kingetsu I, Saito S, Yamada A: Telomerase activity and telomere length of peripheral blood mononuclear cells in SLE patients. Lupus 2003; 12: 591-599.
138. Wu CH, Hsieh SC, Li KJ, Lu MC, Yu CL: Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity. Lupus 2007; 16: 265-272.
139. Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, Markin C, Lawson WE, Xie M, Vulto I, Phillips JA 3rd, Lansdorp PM, Greider CW, Loyd JE: Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007; 356: 1317-1326.
140. Prelog M, Schwarzenbrunner N, Sailer- Hock M, Kern H, Klein-Franke A, Ausserlechner MJ, Koppelstaetter C, Brunner A, Duftner C, Dejaco C, Strasak AM, Muller T, Zimmerhackl LB, Brunner J: Premature aging of the immune system in children with juvenile idiopathic arthritis. Arthritis Rheum 2008; 58: 2153-2162.
141. Bechan GI, Meeker AK, De Marzo AM, Racke F, Jaffe R, Sugar E, Arceci RJ: Telomere length shortening in Langerhans cell histiocytosis. Br J Haematol 2008; 140: 420-428.
142. da Costa CE, Egeler RM, Hoogeboom M, Szuhai K, Forsyth RG, Niesters M, de Krijger RR, Tazi A, Hogendoorn PC, Annels NE: Differences in telomerase expression by the CD1a + cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease. J Pathol 2007; 212: 188-197.
143. MacIntyre A, Brouilette SW, Lamb K, Radhakrishnan K, McGlynn L, Chee MM, Parkinson EK, Freeman D, Madhok R, Shiels PG: Association of increased telomere lengths in limited scleroderma, with a lack of age-related telomere erosion. Ann Rheum Dis 2008; 67: 1780-1782.
144. Tarhan F, Vural F, Kosova B, Aksu K, Cogulu O, Keser G, Gunduz C, Tombuloglu M, Oder G, Karaca E, Doganavsargil E: Telomerase activity in connective tissue diseases: elevated in rheumatoid arthritis, but markedly decreased in systemic sclerosis. Rheumatol Int 2008; 28: 579-583.
145. Colmegna I, Diaz-Borjon A, Fujii H, Schaefer L, Goronzy JJ, Weyand CM: Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum 2008; 58: 990-1000.
146. Guan JZ, Maeda T, Sugano M, Oyama J, Higuchi Y, Suzuki T, Makino N: An analysis of telomere length in sarcoidosis. J Gerontol A Biol Sci Med Sci 2007; 62: 1199-1203.
147. Beier F, Balabanov S, Amberger CC, Hartmann U, Manger K, Dietz K, Kotter I, Brummendorf TH: Telomere length analysis in monocytes and lymphocytes from patients with systemic lupus erythematosus using multi-color flow-fish. Lupus 2007; 16: 955-962.
148. Cong YS, Wright WE, Shay JW: Human telomerase and its regulation. Microbiol Mol Biol Rev 2002; 66: 407-425, table of contents.